Navigation Links
New drug for non-Hodgkin lymphoma and chronic lymphocytic leukemia passes early test
Date:5/23/2014

A new chemotherapy drug being investigated for its potency against two types of cancer was found by scientists at Houston Methodist and seven other institutions to be effective in about one-third of the 58 patients who participated in a phase I study.

The drug, alisertib or MLN8237, inhibits the enzyme aurora A kinase, which is known to be very active during cell division. The present study, published in the journal Investigational New Drugs, looks at the safety, tolerability, and preliminary success of alisertib in treating non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).

"An advantage with this drug is it is oral and very effective in a significant number of patients with aggressive lymphoma when used at that dose for 7 days out a 21 day cycle," said hematologist Swaminathan Iyer, M.D., who led the multi-site study.

Drugs commonly used to treat NHL and CLL are chemotherapeutic drugs and some biological targeted agents such as the monoclonal antibodies rituximab, ofatumumab and obinutuzumab with varying degrees of success.

Although about 1/2 of patients participating in the phase I study experienced side effects most of which were manageable events, Iyer said that is not unusual for such biologic (non chemotherapy) drugs.

"The side effects were fairly tolerable in this study," Iyer said. "We would like to see more information from a larger group of patients to fully understand the drug's safety and tolerability for those experiencing the middle-to-later stages of these diseases."

Iyer and his group recommend 50 mg, twice-daily doses of alisertib for the advanced phase trials of the drug, which Iyer says has begun enrollment.

Alisertib is not yet approved for general medical use by the FDA. Its impact on T cell lymphoma is being investigated in a separate, phase III trial for a specific type of lymphoma called the T cell lymphomas. Houston Methodist is a participating study
'/>"/>

Contact: David Bricker
dmbricker@houstonmethodist.org
832-667-5811
Houston Methodist
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Epigenomic abnormalities predict patient survival in non-Hodgkins lymphoma
2. Novel drug therapy targets aggressive form of non-Hodgkins lymphoma
3. International symposium will address non-Hodgkins lymphoma in the young
4. Inhibition of CDK4 might promote lymphoma development and progression
5. Increased risk of relapse omitting RT in early PET scan negative Hodgkin lymphoma
6. Chemo-free treatment a possibility for leukemia/lymphoma
7. Scientists explore promising new option for first line of attack in lymphoma
8. Breakthrough in treating leukemia, lymphoma with umbilical cord blood stem cells
9. MedMar Healing Center Co-founder Rafael Hernandez Goes the Distance for Leukemia and Lymphoma Society, Running Three Marathons for Nonprofit Health Organization
10. Research shows genetic anti-inflammatory defect predisposes children to lymphoma
11. Reprogrammed treatment-resistant lymphomas respond to cancer drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 26, 2015 Let’s not lose focus ... produce are today’s traffic magnets. Three out of 4 ... of their produce department, according to a Packaged Facts ... people are looking to add more fruits and vegetables ... Manager® Day is April 2. As featured in the ...
(Date:3/26/2015)... 2015 The American College of Traditional Chinese ... topics of the DAOM Program as well as Marketing Basics ... will be hosted by Dr. Carla Wilson, who will give ... on how to prepare for the spring quarter. The webinar ... 27, April 1 and April 3. Attendees can log in ...
(Date:3/26/2015)... MALVERN, PA (PRWEB) March 26, 2015 ... leading providers of continuing medical education, the ... for Culinary Medicine at Tulane University are ... in Culinary Medicine. The interdisciplinary program ... Specialist (CCMS) credential, is designed for physicians, nurse ...
(Date:3/26/2015)... U.S. medical real estate sales transactions ... to an exclusive new report now available only ... (HRE) data firm also announced that it has ... Partners: Harrison Street Real Estate Capital and Zeustra ... going strong, yields compressed, prices per square foot ...
(Date:3/26/2015)... 2015 BioPlus Specialty Pharmacy ... specialty pharmacies, announces the promotion of Sharon Ferrer ... of Pharmaceutical Relations. In this position, Ferrer will ... pharmaceuticals partners and providing key leadership in building ... expansion. , “Over the past seven years ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming Webinars 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 2Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 4Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2
... begun work into improving the lives of thousands of Cystic ... US-Ireland Research and Development Partnership grant. , The grant ... in the USA with funding for the Queen,s component provided ... Public Health Agency), Northern Ireland and the Medical Research Council. ...
... , THURSDAY, Feb. 3 (HealthDay News) -- A special ... disorder (ADHD) in young children, a new study suggests. ... 8 were placed on a diet containing no processed ... percent of them. And, when suspected trouble foods were ...
... bone marrow to become embryonic-like stem cells, a team ... the onset of the blood cancer leukemia in the ... blood cells obtained from a patient with leukemia," says ... directed a study aimed at generating all-purpose stem cells ...
... -- A single dose of the H1N1 swine flu vaccine ... study found. In order to assess the effectiveness of ... -- Canadian researchers looked at 552 patients with flu-like illness ... Dec. 5, 2009. Pandemic H1N1 was detected in 209 ...
... News) -- If you tend to overindulge in food and ... things you can do to ease the ill effects you ... Dr. Cynthia Yoshida offers the following suggestions: Stay ... Caffeine-free, non-carbonated drinks, such as water, can help lessen the ...
... (HealthDay News) -- The average starting salary for a female ... a huge increase from the $3,600 gap in 1999, finds ... difference isn,t known because it isn,t explained by gender differences ... researchers said. The study authors analyzed survey data from ...
Cached Medicine News:Health News:$2.8 million grant boosts cystic fibrosis research at Queen's 2Health News:Restrictive Diet May Reduce ADHD Symptoms 2Health News:Restrictive Diet May Reduce ADHD Symptoms 3Health News:Restrictive Diet May Reduce ADHD Symptoms 4Health News:New induced stem cells may unmask cancer at earliest stage 2Health News:Gender Gap in Starting Doctor Pay Grows 2
(Date:3/26/2015)... , 26. März 2015  Die ... wird vom 1. April 2015 an Zulassungsanträge für ... abgebenden Apotheken annehmen. Seit dem Start des ... Verband über 275 .pharmacy-Domainnamen zugelassen, die für ... Zeiten beantragt wurden. Die NABP startete .pharmacy ...
(Date:3/26/2015)... Mass. , March 26, 2015 /PRNewswire/ ... announced that it will present preclinical and ... at the 2015 American Association for Cancer ... 18-22, 2015 at the Pennsylvania Convention Center in Philadelphia. The presentations ... engineering and nanoliposomal technology platforms, as well ...
(Date:3/26/2015)... -- Gelesis , a clinical stage biotechnology ... to induce weight loss and improve glycemic control, ... of shares of convertible preferred stock for gross ... of approximately $4 million of outstanding convertible promissory ... to support the continued clinical development of its ...
Breaking Medicine Technology:Alle abgebenden Apotheken berechtigt, um ab dem 1. April 2015 .Pharmacy-Domainnamen zu beantragen 2Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 2Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 3Gelesis Closes $22M Equity Financing 2Gelesis Closes $22M Equity Financing 3
... NEW YORK, March 29, 2011 Reportlinker.com announces that ... catalogue: Point of Care Diagnostic Testing ... Point of care testing (POCT) enables rapid ... at the point of care facility where results can ...
... Questcor Pharmaceuticals, Inc. (Nasdaq:  QCOR) announced today that executive management ... April 5-6, 2011 at the New York Palace Hotel in ... Officer, is scheduled to present an overview of the Company ... To listen to the audio web cast of the ...
Cached Medicine Technology:Reportlinker Adds Point of Care Diagnostic Testing World Markets 2Reportlinker Adds Point of Care Diagnostic Testing World Markets 3Reportlinker Adds Point of Care Diagnostic Testing World Markets 4Reportlinker Adds Point of Care Diagnostic Testing World Markets 5Reportlinker Adds Point of Care Diagnostic Testing World Markets 6Reportlinker Adds Point of Care Diagnostic Testing World Markets 7Reportlinker Adds Point of Care Diagnostic Testing World Markets 8Reportlinker Adds Point of Care Diagnostic Testing World Markets 9Reportlinker Adds Point of Care Diagnostic Testing World Markets 10Reportlinker Adds Point of Care Diagnostic Testing World Markets 11Reportlinker Adds Point of Care Diagnostic Testing World Markets 12Reportlinker Adds Point of Care Diagnostic Testing World Markets 13Reportlinker Adds Point of Care Diagnostic Testing World Markets 14Reportlinker Adds Point of Care Diagnostic Testing World Markets 15Reportlinker Adds Point of Care Diagnostic Testing World Markets 16Reportlinker Adds Point of Care Diagnostic Testing World Markets 17Reportlinker Adds Point of Care Diagnostic Testing World Markets 18Reportlinker Adds Point of Care Diagnostic Testing World Markets 19
... STAT analyzer and data management ... to meet the traditional needs of data ... functions for the management of STAT analyzer ... and simple connectivity solution for both STAT ...
... syngo Dynamics network is a ... archiving system using evidence-based reporting ... clinical procedures. It has made ... reality for hospital echocardiography and ...
... dTC is a versatile solution designed to ... from preparation to diagnosis and therapy, ... AXIOM Artis dTC, your cath lab becomes ... that leaves you free to concentrate on ...
... cardiovascular system PLUS ... high-performance transesophageal cardiovascular imaging system ... phased array echocardiography system that ... images, even on your most ...
Medicine Products: